Umut Kefeli

Istanbul Medipol University

H指数:17

被引数:1,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic and Predictive Significance of Body Mass Index in Locally Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy: A Retrospective Multicenter Cohort Study

体重指数在局部晚期胃癌新辅助化疗患者中的预后和预测价值：一项回顾性多中心队列研究

Journal of Clinical Medicine

IF2.9

2026-05-190

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

围手术期FLOT方案后复发性胃和胃食管结合部癌的一线治疗：土耳其肿瘤学组（TOG）多中心真实世界分析

Medicina-Lithuania

IF2.4

2026-05-180

PRE

Seyyar, Mustafa; Sanci, Pervin Can; Sakin, Abdullah; Bayramgil, Ayberk; Kaya, Ozgecan Dulgar; Sunger, Erdem; Acikgoz, Ozgur; Demir, Teyfik; Turkel, Recep; Yilmaz, Bahiddin; Ozalp, Faruk Recep; Semiz, Huseyin Salih; Yildiran, Gul Sema; Aykan, Musa Baris; Turhan, Gorkem; Yildirim, Atila; Menekse, Serkan; Kut, Engin; Cakmak, Mehmet; Algin, Efnan; Sahin, Elif; Karakayali, Anil; Oguz, Aysel; Artac, Mehmet; Icli, Mehmet Cihan; Pacaci, Burak; Sari, Murat; Sakalar, Teoman; Guliyev, Murad; Demirci, Nebi Serkan; Cavdar, Eyyup; Elcicek, Omer Faruk; Inal, Ali; Bolek, Hatice; Tolunay, Pinar Kubilay; Kalem, Ali; Yazici, Melike; Cetinkaya, Aysegul Merc; Akbas, Sinem; Biter, Sedat; Kitapli, Sait; Ozkan, Merve Kuday; Can, Lamia Seker; Majidova, Nargiz; Arak, Haci; Yildirim, Hasan Cagri; Cabuk, Devrim; Uygun, Kazim; Goksu, Sema Sezgin; Tanriverdi, Ozgur; Selcukbiricik, Fatih; Uzun, Mehmet; Okten, Ilker Nihat; Mete, Burak; Koseci, Tolga; Bilici, Ahmet; Kus, Tulay; Dizdar, Omer; Yalcin, Suayib; Kefeli, Umut

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

比较固定剂量与体重基础剂量纳武利尤单抗治疗非小细胞肺癌患者的疗效

Scientific Reports

IF3.9

2026-05-080

OAAI

Muhammet Cengiz; Oktay Bozkurt; Ayse Nuransoy Cengiz; Deniz Can Guven; Elif Sahin; Emel Mutlu Ozkan; Mustafa Ersoy; Ezgi Turkoğlu; Sedat Yildirim; Erdem Kolemen; Beyza Unlu; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Latif Karahan; Mustafa Erman; Ismail Oguz Kara; Meltem Baykara; Pervin Can Sanci; Anıl Karakayali; Umut Kefeli; Devrim Cabuk; Saadettin Kilickap; Teoman Sakalar; Nargiz Majidova; Berrak Mermit Ercek; Muslih Urun; Gözde Agdas; Duygu Bayir; Cengiz Akosman; Erkam Kocaaslan; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; Mevlude Inanc; Metin Ozkan

Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab

苏格兰炎症预后评分在经二线纳武利尤单抗治疗的晚期NSCLC中的预后价值

Discover Oncology

IF2.9

2026-04-210

OAAI

Erdem Kolemen; Kazım Uygun; Devrim Çabuk; Mustafa Erman; Saadettin Kılıçkap; Tolga Köseci; Duygu Bayır; Oktay Bozkurt; Deniz Can Güven; Hacer Demir; Muslih Urun; Sedat Yıldız; Teoman Sakalar; Nargiz Majidova; Emel Mutlu Özkan; Cengiz Akosman; Muhammet Cengiz; Mustafa Ersoy; Elif Şahin; Pervin Can Sancı; Ayşe Nuransoy Cengiz; Gözde Ağdaş; Erkam Kocaaslan; Ezgi Türkoğlu; Sedat Yıldırım; Berrak Mermit Erçek; Anıl Karakayalı; Hayati Arvas; Mehmet Mutlu Kıdı; Sedat Biter; Havva Yeşil Cinkir; Latif Karahan; Aslıhan Ezgi Apaydın Rollas; Umut Kefeli

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab

基线维生素D状态及接受纳武利尤单抗治疗的晚期非小细胞肺癌患者的临床结局

Scientific Reports

IF3.9

2026-04-140

OAAI

Gözde Ağdaş; Duygu Bayir; Elif Şahin; Muhammet Cengiz; Deniz Can Güven; Mehmet Salim Demir; Ertuğrul Bayram; Duygu Özaşkın; Meltem Baykara; Oktay Bozkurt; Mevlüde İnanç; Metin Özkan; Ayşe Nuransoy Cengiz; Mustafa Erman; Umut Kefeli; Emel Mutlu Özkan; Erkam Kocaaslan; Devrim Çabuk; Saadettin Kiliçkap; Pervin Can Sanci; Muslih Urun; Teoman Sakalar; Cengiz Akosman; Erdem Kolemen; Ezgi Turkoğlu; Anıl Karakayali; Mustafa Ersoy; Sedat Yildirim; Latif Karahan; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Berrak Mermit Ercek; Nargiz Majidova; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; İbrahim Karadağ

Real-World Evaluation of the HELPP Score and CALLY Index for Preoperative Prognostic Stratification in Resectable Pancreatic Ductal Adenocarcinoma

真实世界评估HELPP评分和CALLY指数在可切除胰腺导管腺癌术前预后分层中的应用

Journal of Clinical Medicine

IF2.9

2026-03-040

OAAI

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

接受免疫疗法治疗的晚期肺癌患者中，早期肺部免疫预后指数变化的预后意义

Discover Oncology

IF2.9

2026-02-210

OAAI

Muhammet Cengiz; Oktay Bozkurt; Ayşe Nuransoy Cengiz; Mevlude Inanc; Metin Ozkan; Emel Mutlu Ozkan; Deniz Can Guven; Mustafa Erman; Latif Karahan; Elif Sahin; Anıl Karakayali; Pervin Can Sanci; Umut Kefeli; Devrim Cabuk; Erdem Kolemen; Mehmet Mutlu Kidi; Sedat Biter; Tolga Koseci; Muslih Urun; Berrak Mermit Ercek; Duygu Bayir; Gözde Agdas; Teoman Sakalar; Nargiz Majidova; Sedat Yildiz; Hacer Demir; Cengiz Akosman; Mustafa Ersoy; Saadettin Kilickap; Erkam Kocaaslan; Ezgi Turkoğlu; Sedat Yildirim; Hayati Arvas; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Journal of Clinical Medicine

IF2.9

2026-01-260

OAAI

Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring

JOURNAL OF CLINICAL MEDICINE

IF2.9

2025-03-010

OAAI

The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study

镥-177 PSMA-617放射配体治疗转移性去势抵抗性前列腺癌的真实世界结果: 土耳其肿瘤学组多中心研究